Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Nickel, Nils P ^a,b   Lichtinghagen, Ralf ^a   Golpon, Heiko ^a,b   Olsson, Karen M ^a,b   Brand, Korbinian ^a   Welte, Tobias ^a,b   Hoeper, Marius M ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b German Centre for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; CREATININE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; GLYCOPEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GLYCOPEPTIDES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84887775210     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-130     Document Type: Article

References (34)

1. Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 2010, 121:2045-2066. 10.1161/CIRCULATIONAHA.108.847707, 2869481, 20458021.
2. Swiston JR, Johnson SR, Granton JT. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med 2010, 104:1588-1607. 10.1016/j.rmed.2010.08.003, 20810261.
3. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
4. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999, 341:577-585. 10.1056/NEJM199908193410806, 10451464.
5. Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM. Neuroendocrine control of body fluid metabolism. Physiol Rev 2004, 84:169-208. 10.1152/physrev.00017.2003, 14715914.
6. Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology 2006, 105:599-612. quiz 639-540, 10.1097/00000542-200609000-00026, 16931995.
7. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 2003, 7:427-434. 10.1186/cc2337, 374366, 14624682.
8. Robertson GL, Mahr EA, Athar S, Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973, 52:2340-2352. 10.1172/JCI107423, 333039, 4727463.
9. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006, 52:112-119. 10.1373/clinchem.2005.060038, 16269513.
10. Land H, Schutz G, Schmale H, Richter D. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature 1982, 295:299-303. 10.1038/295299a0, 6276766.
11. Katan M, Morgenthaler NG, Dixit KC, Rutishauser J, Brabant GE, Muller B, Christ-Crain M. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab 2007, 92:2640-2643. 10.1210/jc.2006-2046, 17426098.
12. Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008, 19:43-49. 10.1016/j.tem.2007.11.001, 18291667.
13. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 2010, 16(Suppl 1):S37-S44.
14. Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol 2008, 52:266-272. 10.1016/j.jacc.2008.03.050, 18634981.
15. Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, Platonov PG, Hedblad B, Engstrom G, Wang TJ, Melander O. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 2010, 56:1712-1719. 10.1016/j.jacc.2010.05.049, 3005324, 21070922.
16. Nootens M, Kaufmann E, Rector T, Toher C, Judd D, Francis GS, Rich S. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995, 26:1581-1585. 10.1016/0735-1097(95)00399-1, 7594089.
17. de Man FS, Tu L, Handoko ML, Rain S, Ruiter G, Francois C, Schalij I, Dorfmuller P, Simonneau G, Fadel E, et al. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med 2012, 186:780-789. 10.1164/rccm.201203-0411OC, 22859525.
18. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 2004, 110:1308-1312. 10.1161/01.CIR.0000140724.90898.D3, 15337703.
19. James KB, Stelmach K, Armstrong R, Young JB, Fouad-Tarazi F. Plasma volume and outcome in pulmonary hypertension. Tex Heart Inst J 2003, 30:305-307. 307716, 14677741.
20. Forfia PR, Mathai SC, Fisher MR, Housten-Harris T, Hemnes AR, Champion HC, Girgis RE, Hassoun PM. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 177:1364-1369. 10.1164/rccm.200712-1876OC, 2427057, 18356560.
21. Nakamura T, Funayama H, Yoshimura A, Tsuruya Y, Saito M, Kawakami M, Ishikawa SE. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Int J Cardiol 2006, 106:191-195. 10.1016/j.ijcard.2005.01.043, 16321691.
22. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, Roth A, Bickel C, Baldus S, Sinning CR, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010, 55:2096-2106. 10.1016/j.jacc.2010.01.029, 20447532.
23. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010, 122:164-172. 10.1161/CIRCULATIONAHA.109.898122, 20585012.
24. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991, 115:343-349. 10.7326/0003-4819-115-5-343, 1863023.
25. Shah SJ, Thenappan T, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. Circulation 2008, 117:2475-2483. 10.1161/CIRCULATIONAHA.107.719500, 18458173.
26. Brandt RR, Wright RS, Redfield MM, Burnett JC. Atrial natriuretic peptide in heart failure. J Am Coll Cardiol 1993, 22:86A-92A. 10.1016/0735-1097(93)90468-G, 8376700.
27. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 Guidelines for the management of patients with unstable angina/Non ST-elevation myocardial infarction): developed in collaboration with the American college of emergency physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons: endorsed by the American association of cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine. Circulation 2007, 2007(116):e148-e304.
28. Alehagen U, Dahlstrom U, Rehfeld JF, Goetze JP. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA 2011, 305:2088-2095. 10.1001/jama.2011.666, 21610241.
29. Breidthardt T, Irfan A, Klima T, Drexler B, Balmelli C, Arenja N, Socrates T, Ringger R, Heinisch C, Ziller R, et al. Pathophysiology of lower extremity edema in acute heart failure revisited. Am J Med 2012, 125:1124. e1121-1128.
30. Ebert TJ, Cowley AW, Skelton M. Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man. J Clin Invest 1986, 77:1136-1142. 10.1172/JCI112413, 424448, 3514673.
31. Benedict CR JC, Weiner DH, Bourassa MG, Bittner V, Kay RKP, Greenberg B, Kohn RM, Nicklas JM, Mclntyre K, Quinones MAYS. Relation of neurohormoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of studies of left ventricular dysfunction. J Am Coil Cardiol 1994, 23:1410-1420.
32. Fan YH, Zhao LY, Zheng QS, Dong H, Wang HC, Yang XD. Arginine vasopressin increases iNOS-NO system activity in cardiac fibroblasts through NF-kappaB activation and its relation with myocardial fibrosis. Life Sci 2007, 81:327-335. 10.1016/j.lfs.2007.05.018, 17604059.
33. Fukuzawa J, Haneda T, Kikuchi K. Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor. Mol Cell Biochem 1999, 195:93-98. 10.1023/A:1006980517557, 10395073.
34. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009, 135:794-804. 10.1378/chest.08-0492, 19265089.